In this region the first operation decides everything.
Sarcomas punish unplanned surgery more than almost any other tumour — a lump "shelled out" carelessly seeds recurrence. Wide margins, compartment-aware planning and limb salvage are how this region is done properly.
What are sarcomas?
Sarcomas are cancers of the body's structural tissue — muscle, fat, bone, vessels — appearing as lumps in the limbs, trunk or retroperitoneum (deep behind the abdominal organs), or in bone as osteosarcoma and Ewing's, treated here alongside orthopaedic oncology colleagues.
They are rare enough that most lumps get removed casually first — and this is where outcomes are lost. An unplanned excision without imaging, biopsy or margin planning is called a "whoops procedure", and it often forces bigger re-operation than proper first surgery would have needed.
The rule of this region: biopsy and plan before cutting. The first surgery matters most — for cure, and for keeping the limb working.
Eight signals a lump shouldn't be shrugged off
Most lumps are lipomas and cysts. These features are what separate "leave it alone" from "scan it properly".
- ①A lump that keeps growing steadily, wherever it sits.
- ②Any deep lump larger than five centimetres — roughly golf-ball size or beyond.
- ③A painful lump rather than a painless one — pain changes the checklist.
- ④A lump that has returned after previous removal.
- ⑤Swelling of a limb without injury to explain it.
- ⑥A lump recently removed elsewhere without planning or full pathology review — bring every report.
- ⑦A deep mass in thigh, shoulder, trunk or behind the abdomen discovered on any scan.
- ⑧Told it's "just a GIST" or a desmoid? Both deserve specialist management — ask plainly what the plan is.
Tumours we treat in this region
◆Soft-Tissue Sarcoma — Limb & Trunk
Excised wide and compartment-aware, with function preserved.
◆Retroperitoneal Sarcoma
Deep abdominal masses requiring multivisceral planning.
◆Bone Sarcomas
Osteosarcoma and Ewing's — managed jointly with orthopaedic oncology.
◆Desmoid Tumours
Borderline behaviour demands calibrated treatment, not reflex surgery.
◆GIST
Stomach and bowel stromal tumours — targeted therapy plus surgery sequenced correctly.
◆Re-excision Reviews
Previously "shelled out" lumps assessed for proper re-excision before recurrence sets in.
Operations performed here
- P·01Wide, compartment-aware excisionMargins planned on MRI anatomy — not discovered during surgery.
- P·02Limb-salvage surgeryThe default aim; function rated alongside cure.
- P·03Retroperitoneal multivisceral resectionDeep-tumour surgery planned organ by organ beforehand.
- P·04Re-excision of previously shelled-out lumpsCorrecting unplanned first surgeries before they cost more.
- P·05Coordinated radiotherapy & chemotherapy pathwaysSequenced around surgery when the tumour type benefits.
- P·06GIST managementTargeted-therapy-first thinking combined with surgical timing.
From suspicion to surveillance
Listen first
Lump history, old reports and scans reviewed personally.
Image before touching
MRI maps depth, compartments and neighbours.
Biopsy the right way
Track placed along the future incision line — details decide re-excision.
Honest plan
Second opinions welcomed here; sometimes the advice is "your current plan is right".
Surgery once, properly
Wide margins achieved in one planned operation.
Life after
Function assessment plus scheduled surveillance scans.
Families usually ask…
Because sarcomas forgive almost nothing else. An unplanned removal with positive margins usually requires a larger re-operation — sometimes with radiotherapy added — that proper planning would have avoided entirely. The cheapest surgery is the right first surgery.
Limb salvage is achievable in the large majority of cases today, and amputation is recommended only when it genuinely serves survival or quality of life. Either answer comes with reasons you can question.
Removing the tumour together with a surrounding envelope of healthy tissue, so no microscopic cells are left at the edge. It's why incisions and biopsies are mapped before anything is cut.
It behaves like cancer and deserves serious treatment — but unlike most sarcomas, GIST responds remarkably to targeted tablets, often shrinking tumours before surgery. Diagnosis, mutation testing and drug sequencing matter enormously here.
Bring the pathology report and scans. If margins and diagnosis are clean, genuine reassurance costs nothing. If either is incomplete, early re-excision beats waiting for recurrence.